9 completed, 3 not yet recruiting, 2 recruiting, 2 unknown. 6 Phase 4, 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Not yet recruiting 2, Recruiting 1 |
| Phase 1 | 4 | Completed 2, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 4 | Completed 3, Not yet recruiting 1 |
Follow Tinea Versicolor: new trials by email Literature Review of Tinea Versicolor trials Research Report on Tinea Versicolor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor Topical 1 % clotrimazole twice daily 2 weeks, Oral itraconazole 200mg daily for 5 days - Pityriasis Versicolor | Phase 1 / Phase 2 | Not yet recruiting | Combined Military Hospital Abbottabad | 86 | 2026-02-02 | 2026-01-12 |
| Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor. Luliconazole Cream 1%, Topical ketoconazole 2% cream - Pityriasis Versicolor | Phase 4 | Not yet recruiting | PAEC General Hospital, Islamabad | 86 | 2026-02-01 | 2026-01-12 |
| Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor Ketoconazole 2% Shampoo, Placebo Shampoo - Pityriasis Versicolor | Phase 4 | Not yet recruiting | Fakultas Kedokteran Universitas Indonesia | 76 | 2026-02-01 | 2026-03-13 |
| Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor Fluconazole, Itraconazole - Pityriasis Versicolor | Phase 4 | Recruiting | Khyber Teaching Hospital | 106 | 2025-03-01 | 2025-04-10 |
| A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor 20% Cassia alata cream - Tinea Versicolor, Pityriasis Versicolor | Phase 1 | Recruiting | The University of The West Indies | 20 | 2025-03-01 | 2025-11-19 |
| A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor. Ketoconazole Shampoo, 2%, Ketoconazole Shampoo, 2% (Reference Standard), Placebo - Tinea Versicolor | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 430 | 2023-12-04 | 2024-03-12 |
| 8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor 8% sulphur and A. vera soap - Pityriasis Versicolor | Phase 4 | Completed | Universitas Padjadjaran | 42 | 2023-08-25 | 2024-03-26 |
| Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor Fluconazole, Itraconazole - Tinea Versicolor | Phase 1 | Completed | Combined Military Hospital Abbottabad | 164 | 2022-03-01 | 2023-05-17 |
| Vitamin D Level in Recurrent PV Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well) - Recurrent Pityriasis Versicolor | Unknown | Kasr El Aini Hospital | 200 | 2021-09-01 | 2021-10-05 | |
| A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor DBI-002 probiotic gel, Aqueous gel - Tinea Versicolor | Phase 2 | Completed | DermBiont, Inc. | 34 | 2021-03-16 | 2025-07-03 |
| Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19). Cutaneous Manifestations, Skin Manifestations | Completed | Jinnah Postgraduate Medical Centre | 1206 | 2020-07-31 | 2021-11-22 | |
| Gene Polymorphism in Tinea Versicolor Recurrent Pityriasis Versicolor | Unknown | Kasr El Aini Hospital | 200 | 2019-11-01 | 2021-04-26 | |
| The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial shampoo with different composition - Pityriasis Versicolor | Phase 4 | Completed | Universitas Indonesia | 100 | 2018-09-01 | 2019-07-05 |
| Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel voriconazole gel once daily, voriconazole gel twice daily, placebo - Tinea Versicolor | Phase 2 | Completed | Sara Botros | 30 | 2018-02-15 | 2019-10-01 |
| Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel itraconazole gel once daily, itraconazole gel twice daily, placebo - Tinea Versicolor | Phase 2 | Completed | Sara Botros | 30 | 2018-02-15 | 2019-10-01 |
| Ketoconazole Foam 2% for the Treatment of Versicolor Ketoconazole 2% Foam - Tinea Versicolor | Phase 4 | Completed | Boni Elewski, MD | 11 | 2008-11-01 | 2012-08-22 |
COVID-19 (1) · Candidiasis, Oral (1) · Chilblains (1) · Coronavirus Infections (1) · Erythema Multiforme (1) · Herpes Zoster (1) · Livedo Reticularis (1) · Pityriasis Rosea (1) · Pruritus (1) · Purpura Fulminans (1) · Scabies (1) · Skin Manifestations (1) · Stomatitis, Aphthous (1) · Tinea (1)
Bacterial Infections and Mycoses (16) · Dermatomycoses (16) · Infections (16) · Mycoses (16) · Skin Diseases (16) · Skin Diseases, Infectious (16) · Skin and Connective Tissue Diseases (16) · Blood Coagulation Disorders (1) · Candidiasis (1) · Cardiovascular Diseases (1) · Cold Injury (1) · Coronaviridae Infections (1) · DNA Virus Infections (1) · Ectoparasitic Infestations (1) · Embolism and Thrombosis (1)
Itraconazole (3) · Ketoconazole (3) · Fluconazole (2) · BANG polymer gel (1) · Reference Standards (1) · Sulfur (1) · icon infiltrant (1)
Combined Military Hospital Abbottabad (2) · Kasr El Aini Hospital (2) · Sara Botros (2) · Boni Elewski, MD (1) · DermBiont, Inc. (1) · Fakultas Kedokteran Universitas Indonesia (1) · Jinnah Postgraduate Medical Centre (1) · Khyber Teaching Hospital (1) · PAEC General Hospital, Islamabad (1) · Sun Pharmaceutical Industries, Inc. (1) · The University of The West Indies (1) · Universitas Indonesia (1) · Universitas Padjadjaran (1)
Egypt (4) · Pakistan (3) · Indonesia (2) · United States (2) · El Salvador (1) · Jamaica (1)
Sara R Botros, bachelor of clinical pharmacy (2) · Boni E Elewski, MD (1) · David Zepeda, MD (1) · Eliza Miranda, MD, PhD (1) · Jonathan D Ho, MBBS, D.Sc (1) · Natalie Yantovskiy (1) · Rabia Ghafoor, MBBS, FCPS, SCE-Derm(MRCP-UK) (1) · Risa Miliawati Nurul Hidayah, MD, Ph.D (1) · Syeda Mahanum Ali, MBBS, Postgraduate Trainee (1)